Answers are grounded in this paper and cite their sources.
We engineer colloidal quantum dot nanocrystals through the choice of biomolecular ligands responsible for nanoparticle nucleation, growth, stabilization, and passivation. We systematically vary the presence of, and thereby elucidate the role of, phosphate groups and a multiplicity of functionalities on the mononucleotides used as ligands. The results provide the basis for synthesis of nanoparticles using precisely controlled synthetic oligonucleotide sequences.
No takes yet. Share an insight, caveat, or question.
Hinds et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: